Pranshu Mohindra, MD

Dr. Pranshu Mohindra is a radiation oncologist at the University Hospitals Cleveland Medical Center in Cleveland, Ohio. He serves as Professor and Vice-Chair of Operations and Quality for the Department of Radiation Oncology and the Director of the University Hospitals Proton Therapy Center. He specializes in treating thoracic cancers, including pleural mesothelioma. Education and Career

Study Investigating Tumor Microenvironment May Impact Mesothelioma Treatment

Malignant mesothelioma is one of the most challenging diseases confronting modern medicine. The aggressive form of asbestos-related cancer has been resistant to traditional therapies, stymying researchers, frustrating physicians, and devastating patients and their families. A recent study examining variations in lung cancer microenvironments has yielded information that may provide new answers and avenues of exploration

Prakash Neupane, MBBS

Dr. Prakash Neupane is a medical oncologist at the University of Kansas Medical Center in Kansas City, where he specializes in the care of patients with head and neck cancers and thoracic cancers, including lung cancer and pleural mesothelioma. In addition to his clinical role, he is a Professor of Medical Oncology, Program Director of

Gaurav Marwaha, MD

Dr. Gaurav Marwaha is a radiation oncologist, associate professor, and interim chairperson in the Department of Radiation Oncology at Rush University Medical Center in Chicago, Illinois. His areas of expertise include the use of intensity-modulated radiation therapy, palliative radiation therapy, and stereotactic radiosurgery for the treatment of patients diagnosed with lung cancer and pleural mesothelioma,

Arek Z. Dudek, MD, PhD

Dr. Arkadiusz Z. Dudek is a medical oncologist and researcher at the Mayo Clinic in Rochester, Minnesota. He is actively involved in developing new cancer therapeutics for lung cancer, malignant mesothelioma, kidney cancer, and melanoma, as well as other advanced malignancies. His focus is on identifying targets for therapies in order to lead to improvements in

Renuka Malik, MD

Dr. Renuka Malik is a radiation oncologist and associate professor of radiaation and cellular oncology at the University of Chicago Medicine in Chicago, Illinois. She specializes in the treatment of thoracic, gastrointestinal, and oligometastatic cancers including pleural mesothelioma, peritoneal mesothelioma, and lung cancer, as well as gynecologic cancers, prostate cancer, breast cancer, and head and

Alexandra Funaki, DO

Dr. Alexandra Funaki is a diagnostic radiologist at the University of Chicago’s Duchossois Center for Advanced Medicine in Hyde Park, Illinois. She specializes in thoracic imaging, helping to diagnose conditions like pleural mesothelioma, lung cancer, and other complex chest and lung conditions. Education and Career Dr. Funaki earned her medical degree at Midwestern University Chicago

Pavan Mukesh Jhaveri, MD

Dr. Pavan Mukesh Jhaveri is a radiation oncologist who practices at the Dan L. Duncan Comprehensive Cancer Center of Baylor College of Medicine in Houston, Texas, as well as at Baylor Medicine’s Lung Institute. His expertise in the use of innovative radiation oncology tools and techniques is an invaluable addition to Baylor’s multidisciplinary approach to

Mesothelioma Lawsuit Against BNSF Railway Begins Today

Starting this morning, a Helena, Montana jury will begin hearing a claim filed by the families of two Libby, Montana mesothelioma victims. The survivors accuse BNSF Railway of negligently exposing their loved ones to asbestos during the years when the W.R. Grace & Co. mine operated near the town.

Timothy S. Blackwell, MD

Dr. Timothy S. Blackwell is a pulmonologist and critical care medicine specialist who is the chair of the University of Michigan’s Department of Internal Medicine. Dr. Blackwell is nationally recognized for his contributions to the clinical care of patients diagnosed with lung cancer and other pulmonary diseases, as well as for his mentoring of researchers

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now